-
Anti-Hypertensive Drugs Market CAGR to be at 1.7% from 2025 to 2029 | $40.74 Billion Industry Revenue by 2029
09 Dec 2025 15:45 GMT
… the development of new treatments, regulatory alterations and … the importance of medication in managing hypertension varies … Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan
3) … report/pharmaceuticals-global-market-report
Drugs For Hormonal …
-
Sacubitril/Valsartan Shows No Clinical Advantage over enalapril in HF due to Chagas disease: JAMA
06 Dec 2025 11:06 GMT
… complications, and evaluating optimized medical therapy is essential for improving … randomized, 462 received sacubitril/valsartan and 460 received enalapril; target … Open-Label, Multicenter Randomized Clinical Trial. JAMA. Published online December …
-
Influence of Potential Pharmacodynamic Drug Interactions in Pharmacotherapy of Coronary Heart Disease with Comorbid Conditions on Treatment Adherence: A Cross-Sectional Study of a Ukrainian Patient Cohort
14 Nov 2025 21:28 GMT
… antidepressant medicines. The distribution of the number of drugs … 58 clinical trials, patients with … statin therapy of varying intensity, ACE inhibitors, ARBs, sacubitril/valsartan … Single-pill combination to improve hypertension treatment: pharmaceutical …
-
Effect of Qishen Yiqi Dripping Pill on Clinical Outcomes in Patients with Ischemic Heart Failure: A Post-Hoc Analysis of the CACT-IHF Randomized Trial
14 Nov 2025 21:27 GMT
… adjustment of their western medicine treatment plan for HF … QSYQ or placebo treatment (provided by Tasly Pharmaceutical Co., Ltd … at least one trial drug or placebo treatment after randomization. … et al. Sacubitril/valsartan: neprilysin inhibition 5 years …
-
Valsartan Cancer Expert Blocked, Ending First Injury Trial
13 Nov 2025 01:53 GMT
… litigation over contaminated blood pressure medication Valsartan was decided Monday when a … 's medical expert who testified that the drug caused a patient … with a free 7-day trial.
-
AHA 2025: sacubitril/valsartan shows dual edges in resistant hypertension
11 Nov 2025 12:40 GMT
… patients who initiated sacubitril/valsartan between 2016 and 2024.
Resistant … mm Hg despite treatment with three or more antihypertensive medicines, typically including … manageable safety from sacubitril/valsartan.
These findings support sacubitril…
-
Quantitative Evaluation of Cardiac Function Improvement by Conventional Cardiology Drug Regimens Combined with Sacubitril/Valsartan Sodium in Heart Failure Patients
10 Nov 2025 12:48 GMT
… medications: Benazepril Hydrochloride Tablets: Manufactured by Huahai Pharmaceutical … (Production company: Saipei Biotechnology, location: Wuhan, China … treatment efficacy.
Conclusion
Combined conventional cardiology drug treatment and Sacubitril/Valsartan …
-
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
09 Nov 2025 14:00 GMT
… trial is investigating SRD-002, a one-time gene therapy treatment … Food and Drug Administration (FDA) Investigational New Drug (IND) … trials have had little success, except for the use of sacubitril-valsartan … tissues. Global pharmaceutical and academic leaders …
-
How to know if your blood pressure medicine is included in latest FDA recall
07 Nov 2025 16:13 GMT
… of valsartan tablets, many companies, including Teva Pharmaceuticals, recalled the drug … can determine whether your medication came from Teva by … lot numbers on the FDA website for recalled prazosin. … to prescribe an alternative treatment such as clonidine or …
-
FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs
07 Nov 2025 13:56 GMT
… valsartan tablets, many companies, including Teva Pharmaceuticals, recalled the drug at the time.
Drugmakers … numbers on the FDA website for recalled … the medication could cause “temporary or medically … prescribe an alternative treatment such as clonidine …